comparemela.com
Home
Live Updates
Dr Henick on the Use of Neoadjuvant Atezolizumab Plus Chemotherapy in NSCLC : comparemela.com
Dr Henick on the Use of Neoadjuvant Atezolizumab Plus Chemotherapy in NSCLC
Brian Henick, MD, discusses the 3-year updated data from a phase 2 trial investigating treatment with neoadjuvant atezolizumab plus chemotherapy in patients with resectable non–small cell lung cancer.
Related Keywords
,
Brian Henick
,
Columbia University Herbert Irving Comprehensive Cancer Center
,
Experimental Therapeutics
,
Translational Research
,
Aerodigestive Cancers
,
Medical Oncology
,
Lancet Oncology
,
Lung Cancer
,
Onclive Tv
,
comparemela.com © 2020. All Rights Reserved.